On February 22, the Latvian Medicines Verification Organisation (LZVO) held a free seminar for manufacturers of medicines or marketing authorization holders (MAH) on the current developments related to the medicines verification system in Latvia and a look back on what was done in 2022.
At the seminar, MAH representatives had the opportunity to get acquainted with LZVO's achievements in 2022, LZVO's international experience working together with representatives of other national medicines verification organizations and within Arvato working groups, as well as to obtain information about the operations of the medicines verification system in Latvia over a four-year period. Also, the operational priorities of LZVO in 2023 were presented in the seminar, e.g., the introduction of the national AMS (Alert Management System) in Latvia.